Page 45 - MI-2-1
P. 45
Microbes & Immunity iPSC-derived NK cell immunotherapy
Conflict of interest 8. Ritz J, Schmidt RE, Michon J, Hercend T, Schlossman SF.
Characterization of functional surface structures on human
The authors declare no conflicts of interest. natural killer cells. Adv Immunol. 1988;42:181-211.
Author contributions doi: 10.1016/s0065-2776(08)60845-7
Conceptualization: Yiran Zheng, Yumo Zhang, Zhouxin 9. Lanier LL, Le AM, Civin CI, Loken MR, Phillips JH. The
Yang relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen
Writing – original draft: All authors expression on human peripheral blood NK cells and cytotoxic
T lymphocytes. J Immunol. 1986;136(12):4480-4486.
Writing – review & editing: All authors
doi: 10.4049/jimmunol.136.12.4480
Ethics approval and consent to participate 10. Tripathy SK, Keyel PA, Yang L, et al. Continuous engagement
Not applicable. of a self-specific activation receptor induces NK cell
tolerance. J Exp Med. 2008;205(8):1829-1841.
Consent for publication doi: 10.1084/jem.20072446
Not applicable. 11. Lanier LL, Yu G, Phillips JH. Co-association of CD zeta
3
with a receptor (CD16) for IgG Fc on human natural killer
Availability of data cells. Nature. 1989;342(6251):803-805.
Not applicable. doi: 10.1038/342803a0
References 12. Isturiz MA, Geffner JR, Pizzolato MA. Two different
Fc gamma receptor-dependent cytotoxic mechanisms
1. Galy A, Travis M, Cen D, Chen B. Human T, B, natural triggered by monoclonal immunoglobulins. Immunol Lett.
killer, and dendritic cells arise from a common bone marrow 1991;29(3):271-275.
progenitor cell subset. Immunity. 1995;3(4):459-473.
doi: 10.1016/0165-2478(91)90182-a
doi: 10.1016/1074-7613(95)90175-2
13. Tarek N, Le Luduec JB, Gallagher MM, et al. Unlicensed
2. Nagasawa M, Spits H, Ros XR. Innate lymphoid cells (ILCs): NK cells target neuroblastoma following anti-GD2 antibody
Cytokine hubs regulating immunity and tissue homeostasis. treatment. J Clin Invest. 2012;122(9):3260-3270.
Cold Spring Harb Perspect Biol. 2018;10(12):a030304.
doi: 10.1172/JCI62749
doi: 10.1101/cshperspect.a030304
14. Kärre K, Ljunggren HG, Piontek G, Kiessling R.
3. Herberman RB, Nunn ME, Holden HT, Lavrin DH. Natural Selective rejection of H-2-deficient lymphoma variants
cytotoxic reactivity of mouse lymphoid cells against suggests alternative immune defence strategy. Nature.
syngeneic and allogeneic tumors. II. Characterization of 1986;319(6055):675-678.
effector cells. Int J Cancer. 1975;16(2):230-239.
doi: 10.1038/319675a0
doi: 10.1002/ijc.2910160205
15. Kim S, Poursine-Laurent J, Truscott SM, et al. Licensing of
4. Kiessling R, Klein E, Pross H, Wigzell H. “Natural” killer natural killer cells by host major histocompatibility complex
cells in the mouse. II. Cytotoxic cells with specificity for class I molecules. Nature. 2005;436(7051):709-713.
mouse Moloney leukemia cells. Characteristics of the killer
cell. Eur J Immunol. 1975;5(2):117-121. doi: 10.1038/nature03847
doi: 10.1002/eji.1830050209 16. Yu J, Heller G, Chewning J, Kim S, Yokoyama WM,
Hsu KC. Hierarchy of the human natural killer cell
5. Caligiuri MA. Human natural killer cells. Blood. response is determined by class and quantity of inhibitory
2008;112(3):461-469. receptors for self-HLA-B and HLA-C ligands. J Immunol.
doi: 10.1182/blood-2007-09-077438 2007;179(9):5977-5989.
6. Freud AG, Yu J, Caligiuri MA. Human natural killer doi: 10.4049/jimmunol.179.9.5977
cell development in secondary lymphoid tissues. Semin 17. Anfossi N, André P, Guia S, et al. Human NK cell education
Immunol. 2014;26(2):132-137. by inhibitory receptors for MHC class I. Immunity.
doi: 10.1016/j.smim.2014.02.008 2006;25(2):331-342.
7. Holmes ML, Huntington ND, Thong RP, et al. Peripheral doi: 10.1016/j.immuni.2006.06.013
natural killer cell maturation depends on the transcription 18. Groh V, Bahram S, Bauer S, Herman A, Beauchamp M,
factor Aiolos. EMBO J. 2014;33(22):2721-2734.
Spies T. Cell stress-regulated human major histocompatibility
doi: 10.15252/embj.201487900 complex class I gene expressed in gastrointestinal epithelium.
Volume 2 Issue 1 (2025) 37 doi: 10.36922/mi.5653

